AKT1 and cancer: Western blot analyses showed that downregulation of miR-21 via miRzip-21 leads to reduced levels of activated AKT (p-AKT), a downstream target in the PTEN/AKT signaling pathway, in most cancer cells screened except Gli36d as compared to control treated cells.